FLAG and Etoposide as Salvage Treatment in Acute Myeloid Leukemia

被引：1
|
作者：
Papadantonakis, Nikolaos [1 ]
机构：
[1] Univ Alabama Birmingham, Div Hematol Oncol, 1720 2nd Ave S,NP2540U, Birmingham, AL 35294 USA
来源：
ACTA HAEMATOLOGICA | 2020年 / 143卷 / 05期
关键词：
CYTARABINE; FLUDARABINE;
D O I：
10.1159/000504379
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：403 / 404
页数：2
相关论文
共 50 条
  • [1] Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Schmitz, Christine
    Flasshove, Michael
    Duehrsen, Ulrich
    Hanoun, Maher
    ACTA HAEMATOLOGICA, 2020, 143 (05) : 438 - 445
  • [2] Retrospective analysis of FLAG-idarubicin and FLAG-etoposide as salvage therapies in relapsed/refractory acute myeloid leukemia
    Westhus, J.
    Noppeney, R.
    Flasshove, M.
    Duehrsen, U.
    Hanoun, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 43 - 43
  • [3] FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Duehrsen, Ulrich
    Hanoun, Maher
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1014 - 1022
  • [4] Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia
    Hänel, M
    Friedrichsen, K
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Nicklisch, M
    Teich, M
    Ehninger, G
    Fiedler, F
    ONKOLOGIE, 2001, 24 (04): : 356 - 360
  • [5] Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid Leukemia (vol 143, pg 438, 2020)
    Westhus
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 236 - 236
  • [6] FLAG-IDA: A HIGHLY EFFECTIVE SALVAGE REGIMEN IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA
    Virijevic, M.
    Suvajdzic-Vukovic, N.
    Djunic, I.
    Novkovic, A.
    Mitrovic, M.
    Colovic, N.
    Vidovic, A.
    Tomin, D.
    HAEMATOLOGICA, 2013, 98 : 520 - 520
  • [7] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Krogh-Madsen, Mikkel
    Bender, Brendan
    Jensen, Morten Krogh
    Nielsen, Ove Juul
    Friberg, Lena E.
    Honore, Per Hartvig
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1155 - 1163
  • [8] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Mikkel Krogh-Madsen
    Brendan Bender
    Morten Krogh Jensen
    Ove Juul Nielsen
    Lena E. Friberg
    Per Hartvig Honoré
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1155 - 1163
  • [9] Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
    Im, Annie
    Amjad, Ali
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah
    Sehgal, Alison
    Dorritie, Kathleen A.
    Redner, Robert L.
    McLaughlin, Brian
    Shuai, Yongli
    Duggal, Shrina
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2016, 24 (02) : 73 - 80
  • [10] CARBOPLATIN AND ETOPOSIDE IN ACUTE MYELOID-LEUKEMIA
    SANZ, MA
    BONANAD, S
    SANZ, GF
    MARTIN, G
    LEUKEMIA, 1994, 8 (09) : 1599 - 1600
12345